Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sekeres, MA; Othus, M; List, AF; Odenike, O; Stone, RM; Gore, SD; Litzow, MR; Buckstein, R; Fang, M; Roulston, D; Bloomfield, CD; Zhang, Y; Velasco, MR; Gaur, R; Atallah, E; Attar, EC; Appelbaum, FR; Erba, HP

Published Date

  • December 3, 2015

Published In

Volume / Issue

  • 126 / 23

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 57th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Orlando, FL

Conference Start Date

  • December 5, 2015

Conference End Date

  • December 8, 2015